# Olgahospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/olgahospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 94.5 |
| Citations | 199,053 |
| City | Stuttgart |
| Country | DE |
| Description | Olgahospital is a research organisation in Stuttgart, DE. OpenAlex records 6,298 works and 199,053 citations for it. 1,873 researchers list it as their most recent affiliation. |
| Homepage | http://www.klinikum-stuttgart.de/ueber-uns/startseite/olgahospital-frauenklinik/ |
| OpenAlex ID | https://openalex.org/I4210113917 |
| Researchers | 1,873 |
| ROR ID | https://ror.org/01xet8208 |
| Type | healthcare |
| Works | 6,298 |

## University papers

- [Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma](https://scholariq.org/papers/ipilimumab-plus-dacarbazine-for-previously-untreated-metastatic-melanoma/)
- [Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/avelumab-plus-axitinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)
- [Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-cell-carcinoma/)
- [Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-cabozantinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)
- [Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-alone-or-combined-with-chemotherapy-versus-chemotherapy-as-first/)
- [Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines](https://scholariq.org/papers/diagnosis-and-treatment-of-basal-cell-carcinoma-european-consensus-based/)
- [Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016](https://scholariq.org/papers/diagnosis-and-treatment-of-melanoma-european-consensus-based-interdisciplinary/)
- [Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline](https://scholariq.org/papers/diagnosis-and-treatment-of-invasive-squamous-cell-carcinoma-of-the-skin-european/)
- [Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline](https://scholariq.org/papers/diagnosis-and-treatment-of-merkel-cell-carcinoma-european-consensus-based/)
- [European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment](https://scholariq.org/papers/european-interdisciplinary-guideline-on-invasive-squamous-cell-carcinoma-of-the/)
- [European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023](https://scholariq.org/papers/european-consensus-based-interdisciplinary-guideline-for-diagnosis-and-treatment/)
- [Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-sunitinib-in-first-line-treatment-of/)

## University top topics

Showing 8 of 23.

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Health and Medical Studies](https://scholariq.org/topics/health-and-medical-studies/)
- [Pelvic floor disorders treatments](https://scholariq.org/topics/pelvic-floor-disorders-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
